PROCEDURE FOR ASSESSMENT, MONITORING AND DRESSING CHANGE FOR

CENTRAL VENOUS AND ARTERIAL LINES

Table of Contents

  1. Dressing Type
  2. Dressing Change Frequency
  3. Vascular Confirmation
  4. Vascular Device Assessment
  5. Preparation for Arterial and Central Venous Dressing Change


 

  1. Preparing Sterile Tray
  2. Removal of old dressing
  3. Cleansing of Site
  4. Application of Dressing
  5. Documentation and Reporting

Quality and Safety Information

Central line infections are associated with increased length of stay, increased morbidity and morality and increased hospital costs.  The prevention of blood stream infections requires a multi-pronged and multi-team approach to reduce risks during insertion, dressing changes and access of any intravascular device. Click here for our insertion and maintenance bundles and for a copy of the Central Venous and Arterial Line Insertion Checklist and Procedure record.

In addition to strict adherence to aseptic technique and sterile field during arterial line and cetnral venous line insertion, adequate prep and "no-touch technique after prepping" is also required for peripheral IVs, venipunctures and when accessing any intravascular device (e.g., during line flushing, medication administration or continuous infusion of IV therapy) is also essential.  When a patient has a central line in place, any vascular site can become the portal of entry for an organism that will seed on an indwelling device.

Important Known Risk Factors for Central Line Infection:

  • Lines placed during resuscitation efforts or other life-saving interventions (including peripheral)
  • Prolonged use of peripheral IVs
  • Inadequate port prep when accessing an intravascular device
  • Inadequate flushing of intravascular devices after medication administration (2 X 10 ml flushes per port is recommended post medication administration)
  • Positional arterial lines

Equipment Required for Dressing Change with Central Venous and Arterial Line Dressing Tray:

1  Central Venous and Arterial Line Dressing Tray

1  No-sting barrier swab stick (CavilonTM)

1  Extra Chorhexidine 2% and 70% alcohol swab

1  Pair of sterile gloves

1  Securement device for unsutured lines

1  CHG transparent dressing

Sterile clipper head if hair removal is required

Optional: a 10 ml sterile saline syringe may be required if there is a lot of drainage at the insertion site.  The syringe can be emptied into the dressing tray and used with 2X2 gauze.

* if a second person will be assisting, a face shield, cap and non-sterile gown is required.

Equipment Required Using Standard Dressing Tray:

1  Dressing Tray

    Face mask with eye shield

    Non-sterile gown

    Non-sterile gloves for dressing removal

1  No-sting barrier swab stick (CavilonTM)

3   Chorhexidine 2% and 70% alcohol swab sticks

1  Pair of sterile gloves

1  Securement device for unsutured lines

Sterile clipper head if hair removal is required

Optional: a 10 ml sterile saline syringe may be required if there is a lot of drainage at the insertion site.  The syringe can be emptied into the dressing tray and used with 2X2 gauze.

* if a second person will be assisting, a face shield, cap and non-sterile gown is required.

Procedure Rationale
1.

Dressing Type

  • The preferred dressing for arterial and central venous lines is a transparent dressing with CHG pad
  • Unsutured lines require the use of a securement device; this is changed with each dressing change
  • Lines that are actively oozing or where occlusivity cannot be maintained using a transparent dressing should be dressed with a gauze dressing and tape
  • All PICC lines are unsutured
  • We are currently evaluating sutureless strategies for central lines (See Instructions)
  • Avoid the use of bulky dressings on any vascular access device (including post removal)
  • Do not wrap dressing material or tape circumferentially around an arterial line site.

Allergies:

Check for allergies prior to doing dressing and obtain plain transparent dressing or gauze if patient has a CHG allergy.

The most common cause for contact dermatitis is inadequate dry time for CHG prep. If you suspect an allergy to CHG, apply a small test area on the inner arm to confirm/refute allergy.

1.
  • There is evidence of reduced CLI rates when transparent dressing containing a CHG gel pad are used. 
  • Transparent dressings allow daily visualization of the site to identify signs of potential infection. They also protect the site from pathogens while allowing some of the moisture to be drawn away through the "breathable" membrane.
  • Bulky or pressure dressings will not stop bleeding from a vascular device but will delay the detection of serious bleeding
  • Gauze dressings do not allow site visualization
  • Circumferential dressings around a wrist can compromise circulation of the hand.

 

2.

Dressing Change Frequency

Transparent Dressings

  • Change all TRANSPARENT arterial and central venous line dressings Q 7 days (transparent) and PRN to maintain occlusivity
  • Change dressings if CHG pad feels "boggy" to touch or is significantly swollen (pad does not need to be changed if it contains blood unless the volume of fluid in the gel pad is large or lifting the dressing)

Gauze Dressings

  • Change all GAUZE arterial and central venous dressings DAILY and PRN
  • If using tape and gauze on central/arterial lines dressing should be changed daily.
  • Change any dressing that has loosened or lost its occlusive properties.

2.
  • Daily site inspection is a standard supported by CDC and Safethealthcare Now.  If transparent dressings are not being used (which allow for site visualization), dressings should be changed daily to allow site inspection and/or to remove moist dressings.
  • Due to poor skin integrity, diaphoresis etc, dressing changes are done q48hr and prn to remove skin colonization. If the patient is stable with good skin condition, Tegaderm dressings may be left in place for 7 days (per hospital policy).
  • There is no evidence that routine line change dates decrease infection rates; insertion of a new line poses a risk for introducing infection. Lines are changed when evidence of redness or infection is present.
3.

Confirmation of Vascular access:

  • All newly inserted arterial or central venous catheters (including IJ, SC or femoral) must be connected to pressure monitoring and a copy of the waveform posted to the chart. A blood gas is also required.
  • All established arterial or central venous catheters (including IJ, SC or femoral) in patients newly admitted must be connected to pressure monitoring and a copy of the waveform posted to the chart. A blood gas is also required.
  • Chest Xray is required following insertion and admission of a patient with an established line for all upper limb central venous lines (including admission from the OR).

Safety Note: Infusion pumps will continue to run without alarming if a catheter is intra-arterial instead of intravenous.

If an intended central venous catheter has inadvertently been placed into an artery, the waveform will not be visible unless the diastolic blood pressure reading is lower than the top of the scale.

If you cannot identify a waveform in a newly inserted central venous line, increase the scale to 200 to see if a waveform is visible.

All intravascular catheters should display a waveform appropriate to tip location. If no waveform cannot be displayed (despite troubleshooting and expanding the scale size), the line should not be used until the catheter location can be confirmed. Interstitial or intrathoracic placement needs to be ruled-out.

Remember that the tip of a double or triple lumen can be intravascular, but if the catheter is pulled back enough the proximal lumens can be simultaneously interstitial.

If a central venous catheter cannot be identified on Chest Xray, rule out intracranial migration of the catheter.

3.
  • Confirmation of venous placement is required for all IJ, SC and Femoral venous lines to rule out arterial placement. This cannot be done by Xray or ultrasound alone.
  • Inadvertent intraarterial infusion of vasoactive drugs can be limb or life-threatening.
  • Chest Xray is done to identify tip location and to rule out complications such as hemo or pneumothorax.
  • A central venous catheter waveform should be examined to rule out arterial waveform (inadvertent arterial placement) or RV waveform (catheter advanced to deeply).
  • Central venous monitoring is also required on an ongoing basis to evaluate hemodynamic status. Data trends compared to patient response over time are the most important parameters.  CVP readings can be compared to bedside echocardiography findings to help identify optimal pressure targets.
4.

Routine Assessment and Monitoring


At the start of each shift and Q4H

  • Inspect insertion site and surrounding area for signs of redness, discharge, bleeding and catheter kinkage/disrutpion
  • Inspect dressing integrity
  • Palpate the Gel pad for bogginess. Inspect the insertion site around the catheter for swelling, tenderness or crepitus.
  • to determine Determine the amount of exposed catheter at the skin surface if the catheter is not fully advanced
  • Assess distal extremity for color, circulation, motion and swelling
  • Whenever possible, keep dressings exposed or minimize the amount of linen (e.g., a light sheet) that is covering any vascular device to promptly detect bleeding. Check under linens frequently for signs of bleeding and monitor waveform continuously for dampening.
  • Determine any line issues (e.g. positional) and/or insertion bundle compliance concerns. Report to team and document plans for resolution.
  • Review the ongoing need for arterial and central venous lines during team rounds each day.
  • Lines inserted during an emergency procedure where prep time may have been shortened or other breaks in aseptic technique may have occurred should be changed as soon as possible after initial resuscitation (including those inserted in the OR).
4.
  • All insertion sites must be assessed on an ongoing basis for signs of infection, bleeding, thrombosis, interstitial placement or, catehter migration.
  • Crepitus or air in the IV tubing could indicate a cracked catheter or hub or untightened luer lock end. Crepitus can also indicated infection.
  • a catheter hub has been cracked.
  • disruption, Shift and ongoing signs of infection, bleeding, catheter displacement
  • Swelling or impaired circulation distal to an arterial line could indicate limb ischemia due to arterial occlusion from the catheter, from a thrombus or a hematoma.
  • Swelling or impaired circulation distal to a central venous catheter could indicate thrombosis or hematoma (hematoma could also compromise surrounding arterial flow).
  • Hemorrhage can be extensive and rapid from a disconnected or dislodged arterial or central venous catheter.  Signficant blood loss can occur under a thick dressing or layer of blankets.
  • Central venous and arterial lines are indicated if ongoing resuscitation, vasoactive agent infusion or ventilator changes are required.  When a patient no longer requires central venous access, CVP monitoring, frequent blood gases or close blood pressure monitoring, consider changing a central venous line to a PICC or conversion to peripheral IVs.
  • Positional arterial lines, inadquate line anchoring, inadequate flushing and thrombosis are all important risk factors for central venous blood stream infections.

 

Line Tracking Documentation

To identify lines at risk for central line infection, accurate document of a patient with established lines is essential. Documentation should identify where the line was inserted (e.g., in CCTC or another unit/facility), if there is documentation of compliance with the central line insertion bundle or if there were observed breaks in aseptic technique.

If there is no documentation to confirm that aseptic technique was maintained or there were observed breaks in aseptic technique, the line should be flagged as having "issues for review".  This needs to be reported in the following morning rounds and the plans for the line documented.

Confirmation of line placement by blood gas and pressure monitoring upon insertion/admission is documented in the graphic record (ScvO2), by printout of the waveform and in a DAR note by the RN. The RN is also also records the name of the physician who reviewed the Chest Xray to comfirm completion.

The individual who performed the insertion is required to document confirmation of central venous line placement as well as the results of the Chest Xray (for upper limb central venous lines) at the bottom of the Central Venous and Arterial Line Checklist and Procedure Record.

Closing the Loop

The  critical care nurse is expected to identify lines that may need replacement and report issues during morning rounds (or earlier if urgent replacement is required).

The plan for this line should be documented in the AI record under "Plan of Care".  If the plan is not completed on the current shift, it is important to communicate this information to the oncoming shift and to document in the AI record the plan status. If the line change is deferred to the following day, the issue should be presented during morning rounds.

If decisions are made to leave a line in place, there should be physician documentation in the progress note to support the decision. .

New Documentation for Line Trackign will be implemented in ~March 2016. Refer to the Nursing Documentation Standards.

5.

Prepare for Dressing Change

LHSC Procedure for Central Venous or Arterial Line Dressing Changes:

Non-sterile gown, cap and mask with eye shield is required by anyone within one meter of field.

The dressing should be performed using aseptic technique.  This includes preparing the tray using the transfer forceps to add sterile supplies.

A sterile field should be created using drapes provided in the tray. 

Sterile gloves are worn following removal of the dressing and must be worn any touching of the catheter site. Caution should be taken to prevent glove contamination.

Prior to starting, perform a bedside assessment to determine if the patient requires sedation or if an extra pair of hands will be needed to maintain patient positioning and prevent contamination of the sterile field.

The patient should be positioned so that the full area under the dressing is visible and the patient can remain still during the prep time.

When changing an IJ dressing, the ETT or trach ties should be removed on the side of the dressing. If it is not safe to undo the AnchorFast on that side without assistance, request RRT assistance. The entire field needs to be fully exposed to faciliate successful dressing application.

Once the dressing has been applied, the AnchorFast tie can be reconnected and gently positioned on top of the dressing with the lumen over the top of the ties. This enhances adhession (improves with heat and friction) and takes some of the weight from the catheter lumens off the top of the dressing.

If adhesive tape is being used, the tape should not be place over-top of a CVC and care must be taken to ensure it does not slide under the dressing or disrupt it.

Hair should be clipped during the dressing change to enhance adhesion, Shaving is contraindicated.

6.

Prepare Tray

  1. Peform hand hygiene
  2. Open tray at bedside
  3. Don cap, gown, face mask with eye shield
  4. Open sterile tray. Maintain aseptic technique and use the overwrap to create a sterile field.
  5. Open sterile supplies and add to the tray using transfer forceps (don't open and drop them onto the field):
    • Dressing
    • Securement device
    • CHG swab (2 are included with Central Venous and Arterial Line Dressing Tray)
    • If patient has a lot of drainage, add sterile normal saline for a sterile field
  6. Open the top of the no-sting barrier film (Cavilon) and loosen the package. Expose approximately 2 inches of stick, leaving moist swab stick in the package. Lean the no-sting barrier film toward the edge of your sterile field where you can later remove it without contaminating your field (the swab will dry out if you place it on your tray in advance).
6.
7.

Remove Old Dressing

  1. Don non-sterile glvoes (included in dressing change tray)
  2. Secure the dressing with one hand while gently removing existing dressing starting with the securement device
  3. If line a sutureless securement device is being used, remove the dressing over the securement device first.
  4. Remove the securement device using a shoveling movement with the CHG swab.
  5. Once removed, tape the ends of the catheter lumen to the patient maintaining catheter alignment, with tape placed well beyond the area where the new dressing will be located.
  6. Remove remaining dressing
  7. If hair removal is required, clip using the sterile clipper head prior to skin cleansing.
  8. Remove gloves and perform hand hygiene
7.
8.

Cleanse site:

  1. Don sterile gloves
  2. If site is visibly soiled, cleanse area with saline soaked gauze using metal forcep
  3. Dry saline (if use) with a gauze square before prepping with CHG
  4. Scrub the entire area using 2 - CHG 2% and alcohol 70% swabsticks:

Swab 1:

Use an up and down motion while moving from left to right. Turn the swabstick over and scrub the same area using a side to side movement.

Swab 2:

Lift the catheter and cleanse the skin underneath using an up and down motion.  With the unused side of swab to cleanse the undersurface of the tubing.

  1. Ensure a minimum of 2 minutes
  2. Apply no-sting barrier film (Cavilon) to area that will be covered by dressing (excluding the area under the CHG)
  3. Allow the full 1 minute dry time
8.

 

  • The friction produces during scrubbing loosens epithelial cells and improves skin exposure to antiseptic solution.
  • All surfaces of skin and catheter should be cleaned.
  • The most common cause of skin burns and redness is the application of the dressing before the prep has adequately dried. Longer than 2 minutes may be required if more than 2 swabs have been used or the skin is visibly wet.
  • No-sting barrier film enhances dressing adherence and protects the skin.
  • Appication of no-sting under the CHG pad can cause skin burns.

 

Cleaning
9.

Apply Dressing:

  1. Apply securement device
  2. Press and smooth edges of device completely
  3. Position the dressing so that the CHG pad is over the insertion site and the dressing extends to cover the securement device and/or catheter hub.
  4. Gently press the dressing and press toward the edges.  DO NOT STRETCH during application.
  5. Remove the dressing border. 
  6. Remove the anchor strip (still attached to the border) and position it over the bottom of the dressing so that it is half on the skin and half on the actual dressing.
  7. The smooth side of the border paper can be rubbed over the dressing toward the edges enhance adherence.
  8. Date the dressing and update the Kardex.
9.
  • Stretching during application can lead to skin burns.
  • Smoothing the paper over the dressing after dressing application produces heat and friction which improves dressing adherence.
  • Successful dressing application takes time, but results in prolonged adherence with less frequent changes and site exposure over time.
10.

Document

Document the dresssing change and report any abnormal findings to the physician.

Document the plan for abnormal findings.

8.
  • Medical intervention may be required.
 

References

Centre for Disease Control Guidelines for Prevention of Intravascular Catheter-Related Infections. http://www.cd.gov/mmwr/mmwr_rr.htm (August 9, 2002/vol.51/No.RR-10).

Hibbard, J., Mulberry, G., Brady, A. (2002). A clinical study comparing the skin antisepsis and safety of ChloralPrep, 70% Isopropyl Alcohol, and 2% Aqueous Chlorhexidine. Journal of Infusion Nursing. 25(4), 244-249.

Safer Health Care Now (2015). Safer Health Care Now Getting Started Kit: Prevent Central Line Infections, How to Guide. Taken from www.saferhealthcarenow.ca

Tarja J. Karpanen PhD et al. 2016). Clinical evaluation of a chlorhexidine intravascular catheter
gel dressing on short-term central venous catheters
. AJIC. 44(55-60).

Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement
devices for central venous catheters (CVC). Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD010367. DOI: 10.1002/14651858.CD010367.pub2.

 


Last Update: March 23, 2010, February 8, 2016

Morgan, B

LHSCHealth Professionals

Last Updated February 8, 2016 | © 2007, LHSC, London Ontario Canada